Why Is AT&T Stock Dropping?
The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…
Sell
37
SMMNY Quote, Financials, Valuation and Earnings
Last price:
$26.69
Seasonality move
:
-0.53%
Day range:
$26.65 - $26.85
52-week range:
$25.54 - $31.73
Dividend yield:
1.89%
P/E ratio:
28.41x
P/S ratio:
2.47x
P/B ratio:
2.94x
Volume:
43.7K
Avg. volume:
126.2K
1-year change:
-6.35%
Market cap:
$59.7B
Revenue:
$24.3B
EPS (TTM):
$0.94
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
-- | -- | -- | -- | -- |
|
AFMD
Affimed NV
|
$114.5K | -$0.89 | -50.03% | -42.4% | $15.12 |
|
BNTX
BioNTech SE
|
$1.2B | $0.47 | -24.68% | -74.38% | $137.63 |
|
CVAC
CureVac NV
|
$6.9M | -$0.13 | -71.66% | -69.73% | $7.30 |
|
IFRX
InflaRx NV
|
$140.4K | -$0.29 | 5602.11% | -2.23% | $8.06 |
|
IMTX
Immatics NV
|
$16.2M | -$0.31 | -5.77% | -3.64% | $16.42 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
$26.69 | -- | $59.7B | 28.41x | $0.51 | 1.89% | 2.47x |
|
AFMD
Affimed NV
|
$1.15 | $15.12 | $18.9M | -- | $0.00 | 0% | 18.62x |
|
BNTX
BioNTech SE
|
$111.93 | $137.63 | $26.8B | 191.55x | $0.00 | 0% | 8.18x |
|
CVAC
CureVac NV
|
$4.10 | $7.30 | $919.8M | 7.48x | $0.00 | 0% | 1.54x |
|
IFRX
InflaRx NV
|
$2.54 | $8.06 | $149.6M | -- | $0.00 | 0% | 810.37x |
|
IMTX
Immatics NV
|
$5.35 | $16.42 | $650.3M | -- | $0.00 | 0% | 4.29x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
0.52% | 1.527 | 0.16% | 0.86x |
|
AFMD
Affimed NV
|
31.93% | 1.956 | 16.35% | 1.76x |
|
BNTX
BioNTech SE
|
1.26% | 0.632 | 0.96% | 7.10x |
|
CVAC
CureVac NV
|
-- | 1.506 | -- | 6.10x |
|
IFRX
InflaRx NV
|
-- | 3.548 | -- | 4.34x |
|
IMTX
Immatics NV
|
-- | 1.609 | -- | 3.87x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
$2.6B | $1B | 10.39% | 10.64% | 15.58% | $1.3B |
|
AFMD
Affimed NV
|
-- | -$15.7M | -127.62% | -158.94% | -9594.22% | -$13.2M |
|
BNTX
BioNTech SE
|
$1.2B | $11.5M | -2.32% | -2.35% | 13.39% | -$770.2M |
|
CVAC
CureVac NV
|
$519.1M | $404.1M | 21.3% | 21.3% | 75.06% | $381.2M |
|
IFRX
InflaRx NV
|
$216K | -$16.9M | -61.55% | -61.55% | -14084.63% | -$11.2M |
|
IMTX
Immatics NV
|
-- | $565.3K | -16.88% | -16.88% | -4.19% | -$42M |
Siemens Healthineers AG vs. Competitors
-
Which has Higher Returns SMMNY or AFMD?
Affimed NV has a net margin of 9.73% compared to Siemens Healthineers AG's net margin of -9767.12%. Siemens Healthineers AG's return on equity of 10.64% beat Affimed NV's return on equity of -158.94%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.05% $0.30 $20.5B AFMDAffimed NV-- -$1.03 $28.2M -
What do Analysts Say About SMMNY or AFMD?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Affimed NV has an analysts' consensus of $15.12 which suggests that it could grow by 1214.51%. Given that Affimed NV has higher upside potential than Siemens Healthineers AG, analysts believe Affimed NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 AFMDAffimed NV5 0 0 -
Is SMMNY or AFMD More Risky?
Siemens Healthineers AG has a beta of 0.976, which suggesting that the stock is 2.351% less volatile than S&P 500. In comparison Affimed NV has a beta of 2.168, suggesting its more volatile than the S&P 500 by 116.835%.
-
Which is a Better Dividend Stock SMMNY or AFMD?
Siemens Healthineers AG has a quarterly dividend of $0.51 per share corresponding to a yield of 1.89%. Affimed NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. Affimed NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or AFMD?
Siemens Healthineers AG quarterly revenues are $7B, which are larger than Affimed NV quarterly revenues of $170.5K. Siemens Healthineers AG's net income of $677.5M is higher than Affimed NV's net income of -$16.7M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 28.41x while Affimed NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.47x versus 18.62x for Affimed NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.47x 28.41x $7B $677.5M AFMDAffimed NV18.62x -- $170.5K -$16.7M
-
Which has Higher Returns SMMNY or BNTX?
BioNTech SE has a net margin of 9.73% compared to Siemens Healthineers AG's net margin of 15.91%. Siemens Healthineers AG's return on equity of 10.64% beat BioNTech SE's return on equity of -2.35%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.05% $0.30 $20.5B BNTXBioNTech SE85.63% $0.89 $21.6B -
What do Analysts Say About SMMNY or BNTX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand BioNTech SE has an analysts' consensus of $137.63 which suggests that it could grow by 22.97%. Given that BioNTech SE has higher upside potential than Siemens Healthineers AG, analysts believe BioNTech SE is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 BNTXBioNTech SE12 5 0 -
Is SMMNY or BNTX More Risky?
Siemens Healthineers AG has a beta of 0.976, which suggesting that the stock is 2.351% less volatile than S&P 500. In comparison BioNTech SE has a beta of 0.182, suggesting its less volatile than the S&P 500 by 81.764%.
-
Which is a Better Dividend Stock SMMNY or BNTX?
Siemens Healthineers AG has a quarterly dividend of $0.51 per share corresponding to a yield of 1.89%. BioNTech SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. BioNTech SE pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or BNTX?
Siemens Healthineers AG quarterly revenues are $7B, which are larger than BioNTech SE quarterly revenues of $1.4B. Siemens Healthineers AG's net income of $677.5M is higher than BioNTech SE's net income of $217.9M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 28.41x while BioNTech SE's PE ratio is 191.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.47x versus 8.18x for BioNTech SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.47x 28.41x $7B $677.5M BNTXBioNTech SE8.18x 191.55x $1.4B $217.9M
-
Which has Higher Returns SMMNY or CVAC?
CureVac NV has a net margin of 9.73% compared to Siemens Healthineers AG's net margin of 68.44%. Siemens Healthineers AG's return on equity of 10.64% beat CureVac NV's return on equity of 21.3%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.05% $0.30 $20.5B CVACCureVac NV95.56% $1.65 $809.4M -
What do Analysts Say About SMMNY or CVAC?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand CureVac NV has an analysts' consensus of $7.30 which suggests that it could grow by 78.16%. Given that CureVac NV has higher upside potential than Siemens Healthineers AG, analysts believe CureVac NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 CVACCureVac NV3 2 0 -
Is SMMNY or CVAC More Risky?
Siemens Healthineers AG has a beta of 0.976, which suggesting that the stock is 2.351% less volatile than S&P 500. In comparison CureVac NV has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SMMNY or CVAC?
Siemens Healthineers AG has a quarterly dividend of $0.51 per share corresponding to a yield of 1.89%. CureVac NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. CureVac NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or CVAC?
Siemens Healthineers AG quarterly revenues are $7B, which are larger than CureVac NV quarterly revenues of $543.2M. Siemens Healthineers AG's net income of $677.5M is higher than CureVac NV's net income of $371.8M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 28.41x while CureVac NV's PE ratio is 7.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.47x versus 1.54x for CureVac NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.47x 28.41x $7B $677.5M CVACCureVac NV1.54x 7.48x $543.2M $371.8M
-
Which has Higher Returns SMMNY or IFRX?
InflaRx NV has a net margin of 9.73% compared to Siemens Healthineers AG's net margin of -14092.9%. Siemens Healthineers AG's return on equity of 10.64% beat InflaRx NV's return on equity of -61.55%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.05% $0.30 $20.5B IFRXInflaRx NV-5376.61% -$0.33 $72.9M -
What do Analysts Say About SMMNY or IFRX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand InflaRx NV has an analysts' consensus of $8.06 which suggests that it could grow by 217.29%. Given that InflaRx NV has higher upside potential than Siemens Healthineers AG, analysts believe InflaRx NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 IFRXInflaRx NV3 1 0 -
Is SMMNY or IFRX More Risky?
Siemens Healthineers AG has a beta of 0.976, which suggesting that the stock is 2.351% less volatile than S&P 500. In comparison InflaRx NV has a beta of 1.657, suggesting its more volatile than the S&P 500 by 65.659%.
-
Which is a Better Dividend Stock SMMNY or IFRX?
Siemens Healthineers AG has a quarterly dividend of $0.51 per share corresponding to a yield of 1.89%. InflaRx NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. InflaRx NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or IFRX?
Siemens Healthineers AG quarterly revenues are $7B, which are larger than InflaRx NV quarterly revenues of $136.2K. Siemens Healthineers AG's net income of $677.5M is higher than InflaRx NV's net income of -$19.2M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 28.41x while InflaRx NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.47x versus 810.37x for InflaRx NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.47x 28.41x $7B $677.5M IFRXInflaRx NV810.37x -- $136.2K -$19.2M
-
Which has Higher Returns SMMNY or IMTX?
Immatics NV has a net margin of 9.73% compared to Siemens Healthineers AG's net margin of -16.95%. Siemens Healthineers AG's return on equity of 10.64% beat Immatics NV's return on equity of -16.88%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.05% $0.30 $20.5B IMTXImmatics NV-- -$0.12 $427.2M -
What do Analysts Say About SMMNY or IMTX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Immatics NV has an analysts' consensus of $16.42 which suggests that it could grow by 206.85%. Given that Immatics NV has higher upside potential than Siemens Healthineers AG, analysts believe Immatics NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 IMTXImmatics NV5 0 0 -
Is SMMNY or IMTX More Risky?
Siemens Healthineers AG has a beta of 0.976, which suggesting that the stock is 2.351% less volatile than S&P 500. In comparison Immatics NV has a beta of 0.772, suggesting its less volatile than the S&P 500 by 22.769%.
-
Which is a Better Dividend Stock SMMNY or IMTX?
Siemens Healthineers AG has a quarterly dividend of $0.51 per share corresponding to a yield of 1.89%. Immatics NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. Immatics NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or IMTX?
Siemens Healthineers AG quarterly revenues are $7B, which are larger than Immatics NV quarterly revenues of $55.6M. Siemens Healthineers AG's net income of $677.5M is higher than Immatics NV's net income of -$9.4M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 28.41x while Immatics NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.47x versus 4.29x for Immatics NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.47x 28.41x $7B $677.5M IMTXImmatics NV4.29x -- $55.6M -$9.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is American Express Stock Going Lower?
American Express Company (NYSE:AXP) has long been a Buffett favorite…
Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
